Mursla Bio to present at Bio-International 2023
Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event
top of page
News
Search
- May 22
- 1 min
Mursla Bio invited to Health Tech Showcase at London Stock Exchange
Showcase spotlights Mursla Bio's first-in-class science and upcoming milestones for flagship product launch
- May 16
- 3 min
Mursla Bio unlocks new biomarker discovery approach in liquid biopsy and precision medicine
Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023
- Mar 16
- 1 min
Mursla Bio to present at Bio-Europe Spring 2023
Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event in Europe this Spring
- Jan 30
- 1 min
Mursla Bio selected as UK Life Sciences Innovator 2023
Mursla Bio was selected by the UK Department of International Trade to represent UK excellence across the life sciences sector
- Jan 18
- 1 min
Mursla Bio invited to present at the Festival of Genomics and Biodata
Mursla Bio’s cutting edge expertise in extracellular vesicle biology is to be showcased at the world’s largest genomics event
- Sep 28, 2022
- 2 min
Dr Karin Schmitt joins Mursla Bio as Chief Operating Officer
Mursla adds seasoned executive with a wealth of experience in rapid growth and product commercialisation to leadership team
- Apr 13, 2022
- 2 min
Mursla Bio unveils new bead-nanochip technology for ultrasensitive and high throughput EV detection
Novel technology further establishes Mursla Bio’s capabilities to uniquely analyse extracellular vesicle biology for clinical translation
- Mar 29, 2022
- 3 min
Mursla Bio gains support of Roche Diagnostics for pilot study in liver cancer patients
Access to Roche Diagnostics’ expertise in the UK secured in recognition of Mursla’s differentiated value proposition for liquid biopsy
- Mar 1, 2022
- 1 min
Mursla Bio presents its new logo to better reflect its core technology
New logo symbolises the secretion of an extracellular vesicle from its parental cell along with its markers of origin.
- Nov 17, 2021
- 4 min
Mursla Bio announces key appointments to Advisory Board
Key opinion leaders in the fields of Extracellular Vesicles, liquid biopsy and liver disease support Mursla’s ambition
- Oct 20, 2021
- 3 min
Mursla granted patents for novel nanoelectronics detection system for EVs
Mursla has been granted two patents for its novel nanoelectronics-based sensitive detection method for extracellular vesicles.
- Jun 15, 2020
- 1 min
Mursla helping on COVID-19
Mursla is dedicating resources to help improve COVID-19 diagnostics & therapeutics solutions. We are currently capitalising upon our...
- Oct 28, 2019
- 1 min
Cambridge Tech Awards 2019: Mursla among the #OneToWatch
Mursla was selected again as one of the most exciting tech companies to follow in the Cambridge cluster. https://www.cambridgeindependent...
- Mar 12, 2019
- 1 min
Award for innovation in Cambridgeshire and East of England
We are delighted to have won the #onetowatch award as one of the most innovative companies in Cambridgeshire and East of England. The...
Blog
ENG
FR
日本語
.jpg)
ENG
Want to partner with us?
.jpg)
bottom of page